The utility of plasma circulating cell-free messenger RNA as a biomarker of glioma: a pilot study.
Authors
Lim, ChrisFanning, Noel
O'Sullivan, Michael
Nolan, Yvonne
Kaar, George Finbarr
Redmond, Henry Paul
Ita, Michael

Wang, Jiang Huai

Toulouse, Andre

Issue Date
2021-10-13Keywords
BiomarkerGlioma
Circulating cell-free messenger RNA
Metadata
Show full item recordJournal
Acta neurochirurgicaDOI
10.1007/s00701-021-05014-8PubMed ID
34643804PubMed Central ID
PMC8913523Item Type
ArticleOther
Language
enEISSN
0942-0940ae974a485f413a2113503eed53cd6c53
10.1007/s00701-021-05014-8
Scopus Count
Collections
Related articles
- Plasma circulating cell free messenger RNA as a potential biomarker of melanoma.
- Authors: Ita MI, Wang JH, Fanning N, Kaar G, Lim C, Redmond HP
- Issue date: 2021 Sep
- Circulating cell-free messenger RNA enables non-invasive pan-tumour monitoring of melanoma therapy independent of the mutational genotype.
- Authors: Albrecht LJ, Höwner A, Griewank K, Lueong SS, von Neuhoff N, Horn PA, Sucker A, Paschen A, Livingstone E, Ugurel S, Zimmer L, Horn S, Siveke JT, Schadendorf D, Váraljai R, Roesch A
- Issue date: 2022 Nov
- Cell-free circulating tumor DNA in patients with high-grade glioma as diagnostic biomarker - A guide to future directive.
- Authors: Ahmed KI, Govardhan HB, Roy M, Naveen T, Siddanna P, Sridhar P, Suma MN, Nelson N
- Issue date: 2019 Jan-Mar
- A blood-based gene expression and signaling pathway analysis to differentiate between high and low grade gliomas.
- Authors: Ponnampalam SN, Kamaluddin NR, Zakaria Z, Matheneswaran V, Ganesan D, Haspani MS, Ryten M, Hardy JA
- Issue date: 2017 Jan
- A Comprehensive Proteomic SWATH-MS Workflow for Profiling Blood Extracellular Vesicles: A New Avenue for Glioma Tumour Surveillance.
- Authors: Hallal S, Azimi A, Wei H, Ho N, Lee MYT, Sim HW, Sy J, Shivalingam B, Buckland ME, Alexander-Kaufman KL
- Issue date: 2020 Jul 3